You are here

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Physicians’ real-world experience with IDegLira: results of a European survey

https://doi.org/10.1136/bmjdrc-2018-000531corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Drummond R, Baru A, Dutkiewicz M, et al. Physicians’ real-world experience with IDegLira: results of a European survey. BMJ Open Diabetes Research and Care 2018;6:e000531. doi: 10.1136/bmjdrc-2018-000531

    The authors traced some formatting errors in figures 2 and 3. The correct versions are now available below:

    Figure

    Figure 2 Satisfaction of respondents with IDegLira compared with basal-bolus. HbA1c, glycated hemoglobin; IDegLira, insulin degludec/liraglutide.

    Figure

    Figure 3 Respondents’ perceptions on (A) the potential of IDegLira compared with basal-bolus therapy to improve patient motivation to reach their target blood glucose levels; and (B) concerns with IDegLira compared with basal-bolus therapy. GI, gastrointestinal; IDegLira, insulin degludec/liraglutide.

    Linked Articles